Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Alone in Treatment of Favorable, Limited-Stage Hodgkin's Lymphoma: Do We Really Have Robust Data?

被引：2
|
作者：
Basaran, Gul [1 ]
Agaoglu, Fulya [2 ]
Basaran, Mert [2 ]
机构：
[1] Marmara Univ Hosp, Istanbul, Turkey
[2] Istanbul Univ, Inst Oncol, Istanbul, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 27期
关键词：
RADIATION-THERAPY; ABVD CHEMOTHERAPY; RADIOTHERAPY; DISEASE; TRIAL;
D O I：
10.1200/JCO.2010.29.0304
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E485 / E486
页数：2
相关论文
共 18 条
  • [1] Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine for nonbulky limited-stage classical Hodgkin lymphoma
    Abramson, Jeremy S.
    Amason, Jon E.
    LaCasce, Ann S.
    Redd, Robert
    Barnes, Jeffrey A.
    Sokol, Lubomir
    Joyce, Robin
    Avigan, David
    Neuberg, Donna
    Takvorian, Ronald W.
    Hochberg, Ephraim P.
    Bello, Celeste M.
    BLOOD, 2019, 134 (07) : 606 - 613
  • [2] Balancing Risks and Benefits of Therapy for Patients with Favorable-Risk Limited-Stage Hodgkin Lymphoma: The Role of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Chemotherapy Alone
    Hay, Annette E.
    Meyer, Ralph M.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (01) : 49 - +
  • [3] Brentuximab vedotin plus doxorubicin and dacarbazine in nonbulky limited-stage classical Hodgkin lymphoma
    Abramson, Jeremy S.
    Bengston, Elizabeth
    Redd, Robert
    Barnes, Jeffrey A.
    Takvorian, Tak
    Sokol, Lubomir
    Lansigan, Frederick
    Armand, Philippe
    Shah, Bijal
    Jacobsen, Eric
    Martignetti, Rosalba
    Turba, Elyce
    Metzler, Sara
    Patterson, Victoria
    LaCasce, Ann S.
    Bello, Celeste M.
    BLOOD ADVANCES, 2023, 7 (07) : 1130 - 1136
  • [4] Treatment of Favorable, Limited-Stage Hodgkin's Lymphoma With Chemotherapy Without Consolidation by Radiation Therapy
    Canellos, George P.
    Abramson, Jeremy S.
    Fisher, David C.
    LaCasce, Ann S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (09) : 1611 - 1615
  • [5] The Case for Chemotherapy Alone for Limited-Stage Hodgkin's Lymphoma
    Connors, Joseph M.
    ONCOLOGIST, 2012, 17 (08) : 1011 - 1013
  • [6] Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy
    Lagerlof, Ingemar
    Fohlin, Helena
    Enblad, Gunilla
    Glimelius, Bengt
    Goldkuhl, Christina
    Palma, Marzia
    Akesson, Lisa
    Glimelius, Ingrid
    Molin, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (13) : 1487 - 1496
  • [7] Intermediate stage Hodgkin lymphoma in partial remission after three or four courses of doxorubicin, bleomycin, vinblastine dacarbazine: no benefit of one course of intensive chemotherapy before irradiation
    Arakelyan, Nina
    Jais, Jean-Philippe
    Tomowiack, Cecile
    Colombat, Philippe
    Berthou, Christian
    Desablens, Bernard
    Moles-Moreau, Marie-Pierre
    Gastinne, Thomas
    Quittet, Philippe
    Casassus, Philippe
    Le Pourhiet-Le Mevel, Annick
    Ghandour, Christiane
    Briere, Josette
    Colonna, Pierre
    Andrieu, Jean-Marie
    LEUKEMIA & LYMPHOMA, 2013, 54 (01) : 76 - 82
  • [8] ABVD Alone versus Radiation-Based Therapy in Limited-Stage Hodgkin's Lymphoma
    Meyer, Ralph M.
    Gospodarowicz, Mary K.
    Connors, Joseph M.
    Pearcey, Robert G.
    Wells, Woodrow A.
    Winter, Jane N.
    Horning, Sandra J.
    Dar, A. Rashid
    Shustik, Chaim
    Stewart, Douglas A.
    Crump, Michael
    Djurfeldt, Marina S.
    Chen, Bingshu E.
    Shepherd, Lois E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (05) : 399 - 408
  • [9] Limited prognostic value of the International Prognostic Score in advanced stage human immunodeficiency virus infection-related Hodgkin lymphoma treated with the doxorubicin, bleomycin, vinblastine, and dacarbazine regimen
    Xicoy, Blanca
    Ribera, Josep-Maria
    Miralles, Pilar
    Berenguer, Juan
    Rubio, Rafael
    Mahillo, Beatriz
    Valencia, Maria-Eulalia
    Abella, Eugenia
    Lopez-Guillermo, Armando
    Sureda, Ana
    Morgades, Mireia
    Navarro, Jose-Tomas
    Esteban, Herminia
    LEUKEMIA & LYMPHOMA, 2009, 50 (10) : 1718 - 1720
  • [10] Doxorubicin, bleomycin, vinblastine and dacarbazine chemotherapy with interferon for advanced stage classic Hodgkin lymphoma: a 10-year follow-up study
    Batty, Nicolas
    Hagemeister, Fredrick B.
    Feng, Lei
    Romaguera, Jorge E.
    Rodriguez, Maria A.
    McLaughlin, Peter
    Samaniego, Felipe
    Copeland, Amanda
    Dabaja, Bouthaina S.
    Younes, Anas
    LEUKEMIA & LYMPHOMA, 2012, 53 (05) : 801 - 806
12